Skip to main content
OpenTrials
Completed

NCT Number: NCT00899041

Functional Evaluation of a Standard and a High-flexion Knee Prosthesis Using Thigh-calf Contact Force Measurements

The purpose of this study is to investigate whether subjects receiving a high-flexion knee prosthesis show a better knee function than patients receiving a standard knee prosthesis. Thigh-calf contact force measurements are used to quantify knee function. The investigators' hypothesis is that high-flexion knees show a better knee function.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Canisius-Wilhelmina Hospital

Nijmegen, 6532 SZ, Netherlands

About this study

Study title:

Functional evaluation of a standard and a high-flexion knee prosthesis using thigh-calf contact force measurements.

Objective:

The objective of this study is to investigate whether subjects receiving a high flexion knee prosthesis (Sigma RP-F, J&J, UK) show a better knee function than patients receiving a standard knee prosthesis (Sigma FB, J&J, UK).

Study Design:

Prospective double blind randomized study.

Study population:

Subjects who will receive total knee arthroplasty (TKA) because of invalidating gonarthritis based on primary osteoarthritis or rheumatic disorders or trauma.

Intervention:

  • 28 subjects will receive the standard Sigma FB knee prosthesis.
  • 28 subjects will receive the high flexion Sigma RP-F knee prosthesis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients receiving a total knee replacement due to disabling gonarthrosis (cartilage damage):

  • Primary due to osteo-arthritis
  • Secondary due to rheumatoid arthritis or trauma

Exclusion criteria

  • Patients suffering from juvenile rheuma
  • Patients suffering from hemophilia
  • Patients that are incapable to give informed consent
  • Patients who receive a total knee replacement due to an oncological resection
  • Patients who have received a total knee replacement on the contralateral leg
  • Patients who have disabling gonarthrosis on both legs
  • Patients having a BMI < 25 kg/m^2
  • Patients who have to receive a different prosthesis than used in this study for biomechanical reasons (e.g. revision prosthesis)

Treatment and study plan

Total knee arthroplasty (TKA)

Procedure

28 subjects will receive the standard Sigma FB knee prosthesis. 28 subjects will receive the high flexion Sigma RP-F knee prosthesis.

Other names: Sigma RP-F, J&J, UK, Sigma FB, J&J, UK

Primary outcomes

  1. Thigh-calf contact force

    Time frame: pre-op and 1-year post-op

Secondary outcomes

  1. Passive/active maximal knee flexion angle

    Time frame: pre-op and 1-year post-op

  2. BMI, weight and length

    Time frame: pre-op and 1-year post-op

  3. Thigh and calf circumference

    Time frame: pre-op and 1-year post-op

  4. IKS, WOMAC and VAS (pain/satisfaction) score

    Time frame: pre-op and 1-year post-op

Sponsors and collaborators

Lead sponsor

Radboud University Medical Center

Other

Collaborators

  • Canisius-Wilhelmina Hospital
  • Johnson & Johnson Medical BV, The Netherlands

Registry information

Official study title

In-vivo Study Investigating the Difference in Functional Outcome Between Two Types of Knee Prostheses: the Sigma FB (Depuy, J&J, UK; Standard Implant) and the Sigma RP-F (Depuy, J&J, UK; High-flexion Implant)

Important dates

Study start
2008
Primary completion
2013
Study completion
2013
First posted
May 12, 2009
Registry last updated
Nov 8, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.